0001104659-22-123356.txt : 20221130
0001104659-22-123356.hdr.sgml : 20221130
20221130195659
ACCESSION NUMBER: 0001104659-22-123356
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221129
FILED AS OF DATE: 20221130
DATE AS OF CHANGE: 20221130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCCANN JOE A.
CENTRAL INDEX KEY: 0001868644
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39373
FILM NUMBER: 221436831
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: POINT Biopharma Global Inc.
CENTRAL INDEX KEY: 0001811764
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850800493
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
BUSINESS PHONE: (317) 543-9957
MAIL ADDRESS:
STREET 1: 4850 WEST 78TH STREET
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46268
FORMER COMPANY:
FORMER CONFORMED NAME: Therapeutics Acquisition Corp.
DATE OF NAME CHANGE: 20200511
4
1
tm2231716-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-11-29
0
0001811764
POINT Biopharma Global Inc.
PNT
0001868644
MCCANN JOE A.
4850 WEST 78TH STREET
INDIANAPOLIS
IN
46268
1
1
0
0
Chief Executive Officer
Common Stock
2022-11-29
4
P
0
2160
6.64
A
3616313
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.639 to $6.640, inclusive. The Reporting Person undertakes to provide to POINT Biopharma Global Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
/s/ William L. Demers, by Power of Attorney for Joe A. McCann
2022-11-30